159 related articles for article (PubMed ID: 37857784)
1. Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
Chen L; Chi H; Teng J; Meng J; Zhang H; Su Y; Liu H; Ye J; Shi H; Hu Q; Zhou Z; Yang C; Sun Y; Cheng X
Clin Rheumatol; 2024 Jan; 43(1):189-198. PubMed ID: 37857784
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
3. Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA.
Böröcz K; Simon D; Erdő-Bonyár S; Kovács KT; Tuba É; Czirják L; Németh P; Berki T
Clin Exp Immunol; 2021 Jan; 203(1):32-40. PubMed ID: 32959462
[TBL] [Abstract][Full Text] [Related]
4. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
Saxena R; Sturfelt G; Nived O; Wieslander J
Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
6. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
[TBL] [Abstract][Full Text] [Related]
7. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
8. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
[TBL] [Abstract][Full Text] [Related]
9. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
10. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
11. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
12. Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro.
Chen XW; Shen Y; Sun CY; Wu FX; Chen Y; Yang CD
Arthritis Res Ther; 2011 Jan; 13(1):R9. PubMed ID: 21281474
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study.
Beydon M; Nicaise-Roland P; Mageau A; Farkh C; Daugas E; Descamps V; Dieude P; Dossier A; Goulenok T; Farhi F; Mutuon P; Timsit JF; Papo T; Sacre K
Sci Rep; 2022 Jul; 12(1):11244. PubMed ID: 35788140
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
Nehring J; Schirmbeck LA; Friebus-Kardash J; Dubler D; Huynh-Do U; Chizzolini C; Ribi C; Trendelenburg M
Front Immunol; 2018; 9():2090. PubMed ID: 30333817
[No Abstract] [Full Text] [Related]
16. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
Front Immunol; 2019; 10():1026. PubMed ID: 31134086
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
18. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
19. Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus.
Li Z; Lei Z; Yang W; Jing C; Sun X; Yang G; Zhao X; Zhang M; Xu M; Tang Y; Wang Q; Zhao J; Zhou Z; Wen Z; Chen X; Peng Q; Wang G; Zhang P; Sun E; Shen N; Xu W; Li Z; Yang H; Yin Z
Parasit Vectors; 2024 Jan; 17(1):44. PubMed ID: 38291478
[TBL] [Abstract][Full Text] [Related]
20. Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.
Morimoto AM; Flesher DT; Yang J; Wolslegel K; Wang X; Brady A; Abbas AR; Quarmby V; Wakshull E; Richardson B; Townsend MJ; Behrens TW
Arthritis Rheum; 2011 Aug; 63(8):2407-15. PubMed ID: 21506093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
